PharmTech News

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Videos

Pharmaceutical Technology Europe spoke with Ali Rajabi-Siahboomi, vice president and chief innovation officer at Colorcon, about the evolution of coating design and how it has impacted investment, as well as innovations in packaging for oral solid dosage products.

CPHI Milan 2024: Evolution of Coating Design

Pharmaceutical Technology® Europe sat down with Hanns-Christian Mahler from ten23 health to discuss the fill/finish market and sustainability considerations for facilities.

CPHI Milan 2024: Fill/Finish and Sustainability

Zaim Gashi, area sales manager of Steriline, discussed the evolution of aseptic processing equipment in line with current regulatory requirements at CPHI Milan. 

CPHI Milan 2024: Evolution of Aseptic Processing Equipment for Regulatory Compliance

Feliza Mirasol is the science editor for 

CPHI Milan 2024: Industry Trends Impacting Oral Solid Dose Formulation

Pharmaceutical Technology® Europe sat down with Vinod Tuliani, Head of Pharmaceutical Sciences at Roquette, to talk about new developments in the use of excipients in dosage forms and methods of delivery. 

CPHI Milan 2024: The Role of Excipients in Pharmaceuticals

Articles

The winners of this year’s awards showcase achievements in pharma excellence.

Winners of CPHI Excellence in Pharma Awards Announced

Patrick Lavery is an Editor for the MJH Life Sciences brands 

. Previously at MJH, he filled the same role for 

European biotechs have had a strong year in 2024, causing those in the United States to increasingly look to them for innovation.

CPHI Research Forecasts Growth for Biotech, Pharma Markets in 2025

James Hamilton, president of Sharp Sterile, discussed innovation in products associated with sterile manufacturing and industry trends that are driving growth.

CPHI Milan 2024: Growth and Challenges in the Sterile Injectables Market

According to the annual survey, four of the five biggest biologics capacity holders in 2028 will comprise CMOs, which are expected to have 45% of all CMO capacity in Asia.

CMOs and Hybrid Companies Predicted to Hold 54% of Biologics Capacity in 2028, According to CPHI Annual Survey

The company has expanded its NeoFlex coated plungers with new sizes for large-volume auto-injectors and wearable devices. 

CPhI News